IBC's AATD: Advances in Anticoagulant, Antithrombotic and Thrombolytic Drugs
	IBC USA Conferences, Inc. , The Westin Boston-Waltham * Waltham, MA October 2-4, 2000
	AATD 2000, our inaugural event of the new millennium, is well positioned to continue to feature novel targets and compounds under investigation for cardiovascular and thrombotic applications, in addition to comprehensive coverage of the results of new drug trials in stroke and myocardial infarction. Based on overwhelming feedback from past AATD delegates, this year's program will also include a Special Business Strategy Session: Establishing R&D Partnerships. In addition, our 3rd Annual Mini-Symposium on Antiplatelet Therapies will feature a session on Combination Therapy and Drug-Drug Interactions.
	Organized by:	IBC USA Conferences, Inc.
	Deadline for Abstracts:	-
	Registration:	Five Easy Ways to Register! Phone (508) 616-5550 Fax (508) 616-5533 E-mail reg@ibcusa.com Online: www.ibcusa.com/2557 Mail: IBC USA Conferences, Inc. 1 Research Drive, Suite 400A Westborough, MA 01581
	Email for Requests and Registration:	jprudhomme@ibcusa.com
	Posted by: James Prudhomme   Host: 209.6.93.46 date: June 30, 2000 17:52:37 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.